Novem Group
Source: SEC Form 13F · as of Mar 2026Novem Group holds 19 biotech & pharma companies tracked by BioSniper, totaling $26.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$26.4M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 48,228 | $5.8M |
| AMGNAMGEN INC | 14,617 | $5.1M |
| JNJJOHNSON & JOHNSON | 9,071 | $2.2M |
| ABBVAbbVie Inc. | 8,751 | $1.9M |
| LLYELI LILLY & Co | 1,813 | $1.7M |
| NVSNovartis AG | 9,342 | $1.4M |
| UTHRUNITED THERAPEUTICS Corp | 2,323 | $1.4M |
| PRGOPERRIGO Co plc | 123,378 | $1.3M |
| PMPhilip Morris International Inc | 6,082 | $1.0M |
| MEDPMedpace Holdings Inc. | 1,966 | $944K |
| NVONovo Nordisk A/S | 20,869 | $767K |
| BMYBRISTOL MYERS SQUIBB CO | 8,301 | $503K |
| BHVNBiohaven Ltd. | 52,000 | $440K |
| PFEPFIZER INC | 14,589 | $410K |
| MCKMcKesson Corporation | 399 | $345K |
| GILDGILEAD SCIENCES, INC. | 2,424 | $338K |
| IDXXIDEXX LABORATORIES INC /DE | 516 | $290K |
| ABTABBOTT LABORATORIES | 2,782 | $286K |
| HALOHALOZYME THERAPEUTICS, INC. | 3,155 | $204K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.